A practical reference on growth hormone: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-02-24 and is reviewed periodically as new material appears.
Clinical study of tesamorelin has centered on adults with HIV-associated lipodystrophy, a condition in which abdominal fat accumulates while peripheral fat is lost. In controlled trials, treated participants showed reductions in visceral adipose tissue measured by imaging, alongside modest shifts in some lipid values. Effects on subcutaneous fat were smaller and less consistent across studies. Whether these changes translate into fewer cardiovascular events remains an open question, because the trials were not designed or powered to answer it.
Tesamorelin is a synthetic peptide that acts as an analog of growth hormone-releasing hormone, a natural hypothalamic signal. Its sequence corresponds to the forty-four amino acid form of the human hormone, with a small acyl group attached near the amino terminus. That modification slows enzymatic breakdown and extends the time the peptide remains active in circulation. The compound was developed as a pharmacological way to raise endogenous growth hormone output rather than supplying the hormone directly.
Common analytical approaches include reversed-phase high-performance liquid chromatography for purity assessment and mass spectrometry for identity confirmation. Peptide mapping after enzymatic digestion can verify the expected sequence. Immunoassays may be used to measure the compound or its downstream markers, but they can cross-react with related peptides and require careful validation. Impurity profiles typically include truncated sequences, oxidized methionine residues, and residual solvents from synthesis. Each method reports a different property, so no single assay establishes overall quality.
Storage claims vary across suppliers, and published stability data for specific formulations are limited. Extrapolating from related peptides is common but not a substitute for direct measurement. For research use, documentation such as a certificate of analysis is often requested to confirm identity and purity. What constitutes an acceptable purity threshold depends on the intended application. Open questions remain about how temperature excursions during shipping affect long-term peptide integrity. Independent verification by an end user is not routinely reported.
Lyophilized tesamorelin is generally stored refrigerated at 2 to 8 degrees Celsius, protected from light and moisture. Peptides in this class are often kept frozen at minus 20 degrees Celsius for longer periods. Reconstituted solutions are typically used within a defined window because hydrolysis and oxidation proceed faster in liquid form. Container material and headspace also influence how long a preparation retains its expected profile. Specific stability figures depend on concentration and buffer composition.
| Property | Value | Notes |
|---|---|---|
| Drug class | Peptide hormone analog | Acts at the growth hormone-releasing hormone receptor |
| Receptor | Growth hormone-releasing hormone receptor | G protein-coupled; raises cyclic AMP in somatotrophs |
| Key mediator | Insulin-like growth factor 1 | Increases with repeated administration |
| Main studied population | Adults with HIV-associated lipodystrophy | Trials measured visceral adipose tissue by imaging |
| Route | Subcutaneous injection | Given once daily in clinical use |
Clinical investigation has focused on HIV-associated lipodystrophy, a condition in which antiretroviral therapy contributes to abnormal fat distribution. Excess visceral adipose tissue accumulates in the abdomen while peripheral fat may be lost. Tesamorelin was evaluated for reducing this visceral fat depot, with trials measuring changes in abdominal fat by imaging rather than by body weight alone. The rationale rests on the known lipolytic effects of growth hormone. Effects on visceral fat are documented, while long-term outcomes regarding cardiovascular risk remain less clearly established.
Tesamorelin is a synthetic peptide analog of growth hormone-releasing hormone, composed of 44 amino acids. It was designed to retain the biological activity of the native hormone while resisting rapid enzymatic degradation. The compound is classified as a growth hormone secretagogue and belongs to the broader family of hypothalamic releasing factors. In research and clinical settings, it is studied for its ability to stimulate pituitary growth hormone release. Its structure includes a modification at the N-terminus that contributes to an extended half-life relative to native growth hormone-releasing hormone.
Insulin-like growth factor 1 is produced largely in the liver in response to growth hormone signaling. Its concentration shifts over days rather than minutes, which makes it practical for tracking changes across a study period. Interpretation still depends on age, nutritional status, and concurrent illness, all of which independently affect the marker. Reference ranges are therefore stratified, and comparisons are usually made within an individual over time rather than against a single population threshold.
Assays for these markers differ in calibration and antibody specificity, so results from different platforms are not always interchangeable. Reported values can shift when a laboratory changes method, even without any biological change. Studies that span long periods or multiple sites often need cross-validation of assays. This methodological variability is a recognized limitation when comparing findings across published reports, and it remains a topic of ongoing standardization work.
Development work on the compound, originally designated TH9507, focused on conditions in which reduced growth hormone signaling is thought to contribute to altered body composition. The United States Food and Drug Administration approved it in 2010 for the treatment of excess visceral abdominal fat in adults with human immunodeficiency virus infection and lipodystrophy. Later research examined other populations, including adults with mild cognitive impairment, where a large trial did not meet its primary endpoints. This mixed record illustrates how a single mechanism can produce clear effects in one setting and inconclusive results in another.
Several related peptides act on the same receptor, including sermorelin, a shorter GHRH fragment, and modified analogs such as CJC-1295 and modified GRF(1-29) that are common in research settings rather than approved products. Tesamorelin differs from growth hormone itself in that it acts upstream, prompting the pituitary to release the hormone through physiological signaling rather than supplying it directly. Terminology in the literature distinguishes GHRH analogs, growth hormone secretagogues, and recombinant growth hormone, although popular discussion often blurs these categories together. Precise naming matters when comparing study results.
Tesamorelin is a synthetic peptide of 44 amino acids that reproduces the sequence of human growth hormone-releasing hormone (GHRH) and carries a trans-3-hexenoyl group on its N-terminal tyrosine. That small fatty-acid modification blocks cleavage by dipeptidyl peptidase-4, the enzyme that rapidly degrades native GHRH in plasma. The result is a molecule with a longer circulating half-life than the natural hormone while retaining the same receptor target. It is supplied as a lyophilized powder for reconstitution and belongs to the broader class of GHRH analogs studied for effects on pituitary growth hormone secretion.
For example, the pressure needed to drive a viscous fluid up against gravity would contain both that as needed in Poiseuille's law plus that as needed in Bernoulli's equation, such that any point in the flow would have a pressure greater than zero (otherwise no flow would happen). Another example is when blood flows into a narrower constriction, its speed will be greater than in a larger diameter (due to continuity of volumetric flow rate), and its pressure will be lower than in a larger diameter (due to Bernoulli's equation). However, the viscosity of blood will cause additional pressure drop along the direction of flow, which is proportional to length traveled (as per Poiseuille's law). Both effects contribute to the actual pressure drop.
=== Geelong: 2005–2008 === At the start of 2006, he moved out of his Werribee home and moved to Geelong to live with teammates Corey Enright and Henry Playfair, with whom he would later go on to start a personal training organisation. He then set his sights on playing a senior game for Geelong and, after playing in the team that had earlier won the pre-season cup, he was selected to play in round 5. Only minutes into his debut, on 29 April against the Sydney Swans, he broke his arm and only played eight games for the year. After a solid pre-season, he played the first five games of 2007 before being omitted and then broke his wrist while playing for the Geelong VFL side on 8 July 2007. As a result, Prismall was unable to play for several weeks but recovered in time to play finals for the VFL side. In 2008, Prismall played in 11 home and away games and was selected to play in the qualifying final against St Kilda on 7 September 2008, which was to be his 25th game and finals debut. However, midway through the first quarter, he was stretchered off and did not return after landing awkwardly and badly injuring his right knee. It was later confirmed that he would have to undergo a full knee reconstruction after scans revealed a ruptured anterior cruciate ligament. After the 2008 season, Prismall declined the new two-year contract offered to him by Geelong and asked the club to be traded to get a better chance of playing more regularly in the AFL. On the final day of trade week, he was traded to the Essendon Football Club for national draft pick number 39.
=== Neurology and cardiology === Theranostics extends beyond oncology and holds potential in the fields of neurology and cardiology. In neurology, theranostic approaches offer new avenues for the diagnosis and treatment of various neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis. Advanced imaging techniques, including magnetic resonance imaging (MRI) and positron emission tomography (PET), allow for the visualization of neuroanatomy, functional connectivity, and molecular changes in the brain. This enables early detection, precise diagnosis, and monitoring of disease progression, facilitating the development of targeted therapeutic interventions. Similarly, in cardiology, theranostics play a significant role in the diagnosis and treatment of cardiovascular conditions. Non-invasive imaging modalities like MRI and computed tomography (CT) provide detailed information about cardiac structure, function, and blood flow, aiding in the assessment of heart disease and the guidance of interventions. Theranostic approaches in cardiology involve targeted drug delivery systems for the treatment of conditions such as atherosclerosis and restenosis, as well as image-guided interventions for precise stenting or catheter-based therapies.
=== Upcycling === A March 2022 joint study by scientists Sewon Oh and Erin Stache at Cornell University in Ithaca, New York found a new processing method of upcycling polystyrene to benzoic acid. The process involved irradiation of polystyrene with iron chloride and acetone under white light and oxygen for 20 hours. The scientists also demonstrated a similar scalable commercial process of upcycling polystyrene into valuable small-molecules (like benzoic acid) taking just a few hours.
Sources: en.wikipedia.org
The Brazilian press was officially born in Rio de Janeiro on 13 May 1808 with the creation of the Royal Printing National Press by the Prince Regent John. The Gazeta do Rio de Janeiro, the first newspaper published in the country, began to circulate on 10 September 1808. The largest newspapers nowadays are Folha de S.Paulo, O Globo, and O Estado de S. Paulo. Radio broadcasting began on 7 September 1922, with a speech by then President Epitácio Pessoa, and was formalized on 20 April 1923 with the creation of the "Radio Society of Rio de Janeiro". Television in Brazil began officially on 18 September 1950, with the founding of TV Tupi by Assis Chateaubriand. Since then, television has grown in the country, creating large commercial broadcast networks such as Globo, SBT, RecordTV, Bandeirantes and RedeTV. By the mid-1960s, Brazilian universities had installed mainframe computers from IBM and Burroughs Large Systems. In the 1970s and 1980s, the Brazilian government restricted foreign imports to protect the local manufacturing of computers. In the 1980s, Brazil produced half of the computers sold in the country. By 2009, the mobile phone and Internet use in Brazil was the fifth largest in the world. As of early 2025, internet penetration in Brazil stood at 86.2% of the total population (183 million individuals), and the ratio of cellular mobile connections to the total population was 102% (217 million active connections). In May 2010, the Brazilian government launched TV Brasil Internacional, an international television station, initially broadcasting to 49 countries.
The Qatar corruption scandal at the European Parliament, also known as Qatargate, is a cash-for-influence investigation into several Members of the European Parliament and their associates, who are accused of accepting cash and gifts from Qatar and Morocco in return for promoting the interests of those countries in the European Union. The scandal broke on 9 December 2022, when police raided properties in Brussels, seized over €1 million in cash, and arrested a number of suspects, including Greek MEP and Vice-President of the European Parliament Eva Kaili and her partner Francisco Giorgi, a parliamentary assistant. Also detained were Antonio Panzeri, head of an NGO and a former Italian MEP, and Niccolò Figà-Talamanca, head of an NGO. Kaili denied charges of corruption, money-laundering and belonging to a criminal organisation, while her partner admitted his role in the affair. Panzeri agreed to a plea-deal, providing information to the police in return for a reduced sentence. Figà-Talamanca denied the charges. In February 2023, MEPs Marc Tarabella and Andrea Cozzolino were arrested and charged; both deny wrong-doing. In early 2025, former Belgian MEP Marie Arena was charged with belonging to a criminal organisation, which she denies. The origins of the investigation into the scandal date from the spring of 2022, when Belgian security services mounted a surveillance operation against Panzeri, following a tip-off from another European intelligence service that he had been accepting bribes from Morocco.
Sloth World: An Online Sloth Bibliography Picture and information about a ground sloth skeleton on display at the University of Georgia's Science Library Academy of Natural Sciences ground sloth page Illinois State Museum ground sloth page Ground sloths at La Brea Eremotherium in Florida Have some ground sloths survived in Argentina? Ground sloths in general Western Center for Archaeology and Paleontology Hemet, CA
=== Brand endorsement === Morea has also been engaged as a brand ambassador to represent sport leagues, charity organizations, and Indian states. He has endorsed prominent brands including Bisleri Vedica, 7 Up, Close up, Colgate Fresh, Live (in), Calida, Lakmé, Siyaram, Hero Honda CBZ, Monte Carlo and Chronotech. In May 2008, Dino Morea signed up as the brand ambassador for Bangalore Marathon. In September 2009, he became the brand ambassador of Goa Pro Soccer League.
Data from high-throughput chromosome conformation capture experiments, such as Hi-C (experiment) and ChIA-PET, can provide information on the three-dimensional structure and nuclear organization of chromatin. Bioinformatic challenges in this field include partitioning the genome into domains, such as Topologically Associating Domains (TADs), that are organised together in three-dimensional space. Finding the structure of proteins is an important application of bioinformatics. The Critical Assessment of Protein Structure Prediction (CASP) is an open competition where worldwide research groups submit protein models for evaluating unknown protein models.
Sources: en.wikipedia.org
It is a laboratory-made peptide that mimics growth hormone-releasing hormone. It prompts the pituitary gland to release growth hormone and has been studied mainly in adults with HIV-associated lipodystrophy.
Administered growth hormone supplies the hormone directly, while this peptide acts upstream by prompting the pituitary to release it. The indirect route preserves pulsatile secretion and some endogenous feedback, which changes the hormone and IGF-1 profile observed after treatment.
Reductions in visceral adipose tissue appear consistently in randomized trials of the approved population. Effects on peripheral fat, cardiovascular outcomes, and use outside that population are less well established.
Refrigeration between 2 and 8 degrees Celsius with protection from light is the common recommendation. Many laboratories choose frozen storage at minus 20 degrees Celsius when the material will not be used soon. Repeated temperature cycling is generally avoided.